Acadian Asset Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.3M | Sell |
63,025
-4,254
| -6% | -$882K | 0.01% | 532 |
|
|
2026
Q1 | $15.1M | Sell |
67,279
-3,961
| -6% | -$987K | 0.02% | 433 |
|
|
2025
Q4 | $17.2M | Sell |
71,240
-311
| -0.4% | -$79.5K | 0.03% | 362 |
|
|
2025
Q3 | $19.6M | Buy |
71,551
+760
| +1% | +$208K | 0.03% | 336 |
|
|
2025
Q2 | $18.3M | Buy |
70,791
+69,423
| +5,075% | +$16.6M | 0.04% | 332 |
|
|
2025
Q1 | $303K | Sell |
1,368
-1,547
| -53% | -$361K | ﹤0.01% | 1178 |
|
|
2024
Q4 | $664K | Buy |
2,915
+2,360
| +425% | +$568K | ﹤0.01% | 1010 |
|
|
2024
Q3 | $135K | Sell |
555
-3,126
| -85% | -$699K | ﹤0.01% | 1499 |
|
|
2024
Q2 | $704K | Buy |
3,681
+3,037
| +472% | +$616K | ﹤0.01% | 1099 |
|
|
2024
Q1 | $127K | Sell |
644
-144
| -18% | -$26.4K | ﹤0.01% | 1249 |
|
|
2023
Q4 | $134K | Sell |
788
-2,363
| -75% | -$363K | ﹤0.01% | 1310 |
|
|
2023
Q3 | $465K | Buy |
3,151
+2,567
| +440% | +$464K | ﹤0.01% | 1021 |
|
|
2023
Q2 | $127K | Sell |
584
-5,535
| -90% | -$1.23M | ﹤0.01% | 1363 |
|
|
2023
Q1 | $1.34M | Buy |
6,119
+5,638
| +1,172% | +$1.22M | 0.01% | 805 |
|
|
2022
Q4 | $100K | Hold |
481
| – | – | ﹤0.01% | 1432 |
|
|
2022
Q3 | $105K | Hold |
481
| – | – | ﹤0.01% | 1352 |
|
|
2022
Q2 | $101K | Hold |
481
| – | – | ﹤0.01% | 1353 |
|
|
2022
Q1 | $116K | Sell |
481
-148
| -24% | -$35.8K | ﹤0.01% | 1329 |
|
|
2021
Q4 | $163K | Sell |
629
-1,418
| -69% | -$368K | ﹤0.01% | 1279 |
|
|
2021
Q3 | $537K | Buy |
2,047
+1,385
| +209% | +$379K | ﹤0.01% | 1024 |
|
|
2021
Q2 | $164K | Sell |
662
-4,334
| -87% | -$911K | ﹤0.01% | 1500 |
|
|
2021
Q1 | $969K | Buy |
4,996
+569
| +13% | +$114K | ﹤0.01% | 962 |
|
|
2020
Q4 | $940K | Buy |
4,427
+320
| +8% | +$63.8K | ﹤0.01% | 1009 |
|
|
2020
Q3 | $704K | Sell |
4,107
-3,976
| -49% | -$734K | ﹤0.01% | 1025 |
|
|
2020
Q2 | $1.55M | Buy |
8,083
+793
| +11% | +$130K | 0.01% | 811 |
|
|
2020
Q1 | $1.07M | Sell |
7,290
-3,393
| -32% | -$540K | 0.01% | 773 |
|
|
2019
Q4 | $1.66M | Buy |
10,683
+10,182
| +2,032% | +$1.47M | 0.01% | 745 |
|
|
2019
Q3 | $68K | Buy |
501
+20
| +4% | +$2.62K | ﹤0.01% | 1568 |
|
|
2019
Q2 | $59K | Hold |
481
| – | – | ﹤0.01% | 1453 |
|
|
2019
Q1 | $50K | Sell |
481
-8,050
| -94% | -$831K | ﹤0.01% | 1677 |
|
|
2018
Q4 | $971K | Sell |
8,531
-680
| -7% | -$72.9K | ﹤0.01% | 735 |
|
|
2018
Q3 | $1.06M | Buy |
9,211
+8,730
| +1,815% | +$956K | ﹤0.01% | 714 |
|
|
2018
Q2 | $50K | Hold |
481
| – | – | ﹤0.01% | 1387 |
|
|
2018
Q1 | $47K | Hold |
481
| – | – | ﹤0.01% | 1369 |
|
|
2017
Q4 | $41K | Hold |
481
| – | – | ﹤0.01% | 1259 |
|
|
2017
Q3 | $37K | Hold |
481
| – | – | ﹤0.01% | 1143 |
|
|
2017
Q2 | $37K | Hold |
481
| – | – | ﹤0.01% | 1174 |
|
|
2017
Q1 | $35K | Hold |
481
| – | – | ﹤0.01% | 1295 |
|
|
2016
Q4 | $30K | Sell |
481
-197,263
| -100% | -$12.1M | ﹤0.01% | 1260 |
|
|
2016
Q3 | $12.8M | Sell |
197,744
-152,860
| -44% | -$10.2M | 0.06% | 240 |
|
|
2016
Q2 | $22.2M | Buy |
350,604
+84,652
| +32% | +$4.99M | 0.11% | 168 |
|
|
2016
Q1 | $15.4M | Buy |
265,952
+237,405
| +832% | +$13.4M | 0.08% | 226 |
|
|
2015
Q4 | $1.53M | Buy |
+28,547
| New | +$1.61M | 0.01% | 621 |
|
|
2015
Q3 | – | Sell |
-42
| Closed | -$2K | – | 1410 |
|
|
2015
Q2 | $2K | Buy |
42
+21
| +100% | +$1.32K | ﹤0.01% | 1322 |
|
|
2015
Q1 | $2K | Hold |
21
| – | – | ﹤0.01% | 1326 |
|
|
2014
Q4 | $1K | Buy |
+21
| New | +$1.1K | ﹤0.01% | 1251 |
|
Other funds holding RMD
VCM
VPM
Acadian Asset Management's RMD Position: Q2 2026 in Review
Acadian Asset Management reduced its ResMed (RMD) stake by 6.3% in Q2 2026, selling an estimated $882K and leaving 63,025 shares worth $12.3M. The position accounts for 0.01% of the portfolio, ranked #532.
Acadian Asset Management first reported a position in RMD in Q4 2014 and has held it in 46 quarters since. The position peaked at $22.2M in Q2 2016. 707 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Acadian Asset Management held 63,025 shares of ResMed worth $12.3M as of Q2 2026.
- Acadian Asset Management sold 4,254 ResMed shares in Q2 2026, an estimated $882K.
- ResMed made up 0.01% of Acadian Asset Management's portfolio in Q2 2026, its #532 holding.
- Acadian Asset Management first reported a position in ResMed in Q4 2014 and has held it in 46 quarters since.
- Acadian Asset Management's ResMed position peaked at $22.2M in Q2 2016.
- 707 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.